14
edits
Alessandro (talk | contribs) m (added a word for clarity) |
|||
(18 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
The '''prostate gland''' adds juice to the sperm. In old men it creates | [[Image:Prostatelead.jpg|thumb|right|200px|The prostate gland and its surrounding structures. (WC/NCI)]] | ||
The '''prostate gland''' adds juice to the sperm. In old men it creates a lot of problems... [[nodular hyperplasia]] (commonly called BPH or [[benign prostatic hyperplasia]]) and cancer (usually adenocarcinoma). | |||
[[Prostate cancer]] is such a big topic it is dealt with in its own article. | [[Prostate cancer]] is such a big topic it is dealt with in its own article. | ||
The female homologue of the prostate gland is considered to be Skene's gland.<ref name=pmid8522254>{{Cite journal | last1 = Dodson | first1 = MK. | last2 = Cliby | first2 = WA. | last3 = Pettavel | first3 = PP. | last4 = Keeney | first4 = GL. | last5 = Podratz | first5 = KC. | title = Female urethral adenocarcinoma: evidence for more than one tissue of origin? | journal = Gynecol Oncol | volume = 59 | issue = 3 | pages = 352-7 | month = Dec | year = 1995 | doi = 10.1006/gyno.1995.9963 | PMID = 8522254 }}</ref> | |||
=Normal prostate gland= | =Normal prostate gland= | ||
Line 16: | Line 19: | ||
**Second cell layer may be difficult to see (like in breast). | **Second cell layer may be difficult to see (like in breast). | ||
*Epithelium in glands is "folded" or "tufted". | *Epithelium in glands is "folded" or "tufted". | ||
**Very important - helps | **Very important - helps to differentiate from Gleason pattern 3. | ||
*Luminal epithelium often clear cytoplasm. | *Luminal epithelium often clear cytoplasm. | ||
*Single nucleus. | *Single nucleus. | ||
Line 33: | Line 36: | ||
Notes: | Notes: | ||
*Tufted epithelium is a strong indicator of benignancy; however two uncommon prostate cancer typically have tufted epithelium: | *Tufted epithelium is a strong indicator of benignancy; however two uncommon prostate cancer variants typically have tufted epithelium: | ||
**[[Pseudohyperplastic adenocarcinoma]]. | **[[Pseudohyperplastic adenocarcinoma]]. | ||
**[[Foamy gland carcinoma]]. | **[[Foamy gland carcinoma]]. | ||
Line 45: | Line 48: | ||
==IHC of normal prostate== | ==IHC of normal prostate== | ||
Normal prostate: | Normal prostate: | ||
*AMACR -ve (mark epithelial cells). | *[[AMACR]] -ve (mark epithelial cells). | ||
*CK5/6 +ve,<ref name=pmid19605815>{{Cite journal | last1 = Trpkov | first1 = K. | last2 = Bartczak-McKay | first2 = J. | last3 = Yilmaz | first3 = A. | title = Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. | journal = Am J Clin Pathol | volume = 132 | issue = 2 | pages = 211-20; quiz 307 | month = Aug | year = 2009 | doi = 10.1309/AJCPGFJP83IXZEUR | PMID = 19605815 }}</ref> p63 +ve, HMWCK +ve (mark basal cells). | *[[CK5/6]] +ve,<ref name=pmid19605815>{{Cite journal | last1 = Trpkov | first1 = K. | last2 = Bartczak-McKay | first2 = J. | last3 = Yilmaz | first3 = A. | title = Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. | journal = Am J Clin Pathol | volume = 132 | issue = 2 | pages = 211-20; quiz 307 | month = Aug | year = 2009 | doi = 10.1309/AJCPGFJP83IXZEUR | PMID = 19605815 }}</ref> p63 +ve, HMWCK +ve (mark basal cells). | ||
*PSA (prostate-specific antigen) +ve, PSAP (prostatic-specific acid phosphatase) +ve. | *PSA ([[prostate-specific antigen]]) +ve, PSAP ([[prostatic-specific acid phosphatase]]) +ve. | ||
==Sign out== | ==Sign out== | ||
Line 68: | Line 71: | ||
==Bulbourethral gland== | ==Bulbourethral gland== | ||
*[[AKA]] ''Cowper's gland''. | *[[AKA]] ''Cowper's gland''. | ||
{{Main|Bulbourethral gland}} | |||
==Seminal vesicles== | ==Seminal vesicles== | ||
Line 99: | Line 77: | ||
=Specimens= | =Specimens= | ||
*Prostate core biopsy - done transrectal. | *[[Prostate core biopsy]] - done transrectal. | ||
*Prostate chips (from a ''transurethral resection of the prostate'', abbreviated ''TURP'') - usu. done for [[nodular hyperplasia of the prostate gland]]; may be done in the context of obstructing cancer. | *[[Prostate chips]] (from a ''transurethral resection of the prostate'', abbreviated ''TURP'') - usu. done for [[nodular hyperplasia of the prostate gland]]; may be done in the context of obstructing cancer. | ||
*Radical prostatectomy - includes the [[seminal vesicles]]. | *[[Radical prostatectomy]] - includes the [[seminal vesicles]]. | ||
*Radical cystoprostatectomy - includes the [[urinary bladder]] and [[seminal vesicles]].<ref>URL: [http://www.cancer.gov/dictionary?cdrid=446218 http://www.cancer.gov/dictionary?cdrid=446218]. Accessed on: 23 February 2012.</ref> | *[[Radical cystoprostatectomy]] - includes the [[urinary bladder]] and [[seminal vesicles]].<ref>URL: [http://www.cancer.gov/dictionary?cdrid=446218 http://www.cancer.gov/dictionary?cdrid=446218]. Accessed on: 23 February 2012.</ref> | ||
=Approach= | =Approach= | ||
Line 110: | Line 88: | ||
==Common diagnoses== | ==Common diagnoses== | ||
*Benign. | *Benign. | ||
**[[ | **[[Atrophy of the prostate|Atrophy]] - may resemble adenocarcinoma - typically not reported. | ||
**Adenosis - may resemble adenocarcinoma - typically not reported. | **[[Adenosis of the prostate|Adenosis]] - may resemble adenocarcinoma - typically not reported. | ||
*[[Prostate adenocarcinoma]]. | *[[Prostate adenocarcinoma]]. | ||
*[[HGPIN]] (high-grade prostatic intraepithelial neoplasia) - prostate adenocarcinoma precursor lesion. | *[[HGPIN]] (high-grade prostatic intraepithelial neoplasia) - prostate adenocarcinoma precursor lesion. | ||
*[[ASAP]] (atypical small acinar proliferation) - used if you have a few abnormal appearing glands... but can't decide between prostate adenocarcinoma & benign. | *[[ASAP]] (atypical small acinar proliferation) - used if you have a few abnormal appearing glands... but can't decide between prostate adenocarcinoma & benign. | ||
Line 125: | Line 102: | ||
=Clinical history= | =Clinical history= | ||
*PSA (serum). | {{Main|Prostate specific antigen}} | ||
*[[PSA]] (serum). | |||
** >10 ng/mL worrisome for prostate cancer. | ** >10 ng/mL worrisome for prostate cancer. | ||
** Normal is age dependent - increases with age, usu. cut-off ~ 4 ng/mL. | ** Normal is age dependent - increases with age, usu. cut-off ~ 4 ng/mL. | ||
*HIFU = ''High Intensity Focused Ultrasound'' - an ablation procedure for prostate cancer.<ref>URL: [http://www.internationalhifu.com/what-is-hifu-mainmenu-132.html http://www.internationalhifu.com/what-is-hifu-mainmenu-132.html]. Accessed on: 15 June 2010.</ref> | *HIFU = ''High Intensity Focused Ultrasound'' - an ablation procedure for prostate cancer.<ref>URL: [http://www.internationalhifu.com/what-is-hifu-mainmenu-132.html http://www.internationalhifu.com/what-is-hifu-mainmenu-132.html]. Accessed on: 15 June 2010.</ref> | ||
= | =Benign changes and remnants= | ||
==Adenosis of the prostate gland== | |||
*[[AKA]] ''atypical adenomatous hyperplasia of the prostate gland'' (or ''atypical adenomatous hyperplasia''). | |||
{{Main|Adenosis of the prostate gland}} | |||
==Basal cell hyperplasia of the prostate== | |||
{{Main|Basal cell hyperplasia of the prostate}} | |||
==Atrophy of the prostate== | |||
*[[AKA]] ''atrophy''. | |||
*[[AKA]] ''prostatic atrophy''. | |||
*[[AKA]] ''atrophy of the prostate gland''. | |||
{{Main|Atrophy of the prostate gland}} | |||
==Mesonephric remnant of the prostate gland== | |||
{{Main|Mesonephric remnant of the prostate gland}} | |||
=Benign conditions= | |||
==Prostatic nodular hyperplasia== | ==Prostatic nodular hyperplasia== | ||
*[[AKA]] ''nodular hyperplasia of the prostate''. | *[[AKA]] ''nodular hyperplasia of the prostate''. | ||
Line 218: | Line 213: | ||
==Granulomatous prostatitis== | ==Granulomatous prostatitis== | ||
{{Main|Granulomatous prostatitis}} | {{Main|Granulomatous prostatitis}} | ||
==Prostatic infarct== | ==Prostatic infarct== | ||
Line 303: | Line 237: | ||
*[http://www.sciencephoto.com/media/258565/enlarge Prostatic thrombosis (sciencephoto.com)]. | *[http://www.sciencephoto.com/media/258565/enlarge Prostatic thrombosis (sciencephoto.com)]. | ||
== | =Preneoplastic changes and atypical changes= | ||
==High-grade prostatic intraepithelial neoplasia== | ==High-grade prostatic intraepithelial neoplasia== | ||
*Abbreviated as ''HGPIN''. | *Abbreviated as ''HGPIN''. | ||
Line 342: | Line 248: | ||
**''ASAP'' is preferred as it does not contain the word ''carcinoma'' and, thus, cannot be misread as ''carcinoma'', i.e. positive for malignancy. | **''ASAP'' is preferred as it does not contain the word ''carcinoma'' and, thus, cannot be misread as ''carcinoma'', i.e. positive for malignancy. | ||
{{Main|Atypical small acinar proliferation}} | {{Main|Atypical small acinar proliferation}} | ||
=Prostate cancer= | =Prostate cancer= | ||
Line 357: | Line 260: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: Genitourinary pathology]] | [[Category: Genitourinary pathology]] |
edits